Halozyme Therapeutics Inc. (HALO) News Nov 20, 2014, 5:14

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 8:38 PM

Halozyme Therapeutics Inc. (HALO) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on HALO
Fossil Group swings higher on earnings beat, license renewal 6:30 a.m. Nov. 12, 2014 - Wallace Witkowski
Amazon gains on June event; PVH sinks on results 2:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 8:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 7:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 3:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 5:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 8:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 7:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 11:40 a.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 5:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 1:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 5:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 3:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 10:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy

Other News on HALO
Biggest Movers in Healthcare Stocks Now – CLDX ALGN WST PDCO 12:45 p.m. Nov. 12, 2014 - InvestorPlace.com
Halozyme Therapeutics (HALO) Stock Is Slipping Today on Weak Third Quarter Earnings 11:42 a.m. Nov. 11, 2014 - TheStreet.com
Halozyme Therapeutics' (HALO) CEO Helen Torley on Q3 2014 Results - Earnings Call Transcript 9:33 p.m. Nov. 10, 2014 - Seeking Alpha
10-Q: HALOZYME THERAPEUTICS INC 4:50 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Halozyme Therapeutics Plummets On Q3 Losses 4:19 p.m. Nov. 10, 2014 - benzinga.com
NewLink Genetics Corporation (NLNK) in Focus: Stock Soars 15.4% - Tale of the Tape 9:18 a.m. Oct. 23, 2014 - Zacks.com
Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog 5:54 p.m. Oct. 22, 2014 - Zacks.com
Biogen's Q3 Earnings Top Estimates, View Raised Again - Analyst Blog 1:10 p.m. Oct. 22, 2014 - Zacks.com
Actelion Misses Q3 Earnings Expectation, Ups 2014 Guidance - Analyst Blog 11:40 a.m. Oct. 22, 2014 - Zacks.com
Orexigen (OREX) Shows Strength: Stock Gains 11.1% - Tale of the Tape 9:25 a.m. Oct. 22, 2014 - Zacks.com
Illumina (ILMN) Looks Strong: Stock Gains 9.2% - Tale of the Tape 8:44 a.m. Oct. 22, 2014 - Zacks.com
NewLink-Roche Ink Deal for Oncology Candidate Development - Analyst Blog 6:05 p.m. Oct. 21, 2014 - Zacks.com
Illumina (ILMN) Tops Q3 Earnings, Revenues; Ups Guidance - Analyst Blog 9:40 a.m. Oct. 21, 2014 - Zacks.com
Vital Therapies (VTL) in Focus: Stock Adds 7.9% in Session - Tale of the Tape 9:39 a.m. Oct. 21, 2014 - Zacks.com
NewLink Genetics Corp. (NLNK) Jumps: Stock Rises 7.1% - Tale of the Tape 8:51 a.m. Oct. 21, 2014 - Zacks.com
Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog 6:35 p.m. Oct. 20, 2014 - Zacks.com
Regeneron Pharmaceuticals (REGN) Jumps: Stock Up 8.5% - Tale of the Tape 9:39 a.m. Oct. 20, 2014 - Zacks.com
Emergent BioSolutions (EBS) Jumps: Stock Moves Up 5.8% - Tale of the Tape 8:51 a.m. Oct. 20, 2014 - Zacks.com
Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog 5:00 p.m. Oct. 17, 2014 - Zacks.com
Novavax (NVAX) Moves Up: Stock Adds 10.1% in Session - Tale of the Tape 9:39 a.m. Oct. 17, 2014 - Zacks.com

Press Releases on HALO
Halozyme Reports Third Quarter 2014 Financial Results 4:05 p.m. Nov. 10, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference 4:15 p.m. Nov. 5, 2014 - PR Newswire - PRF
Halozyme to Host Third Quarter 2014 Financial Results Conference Call 4:15 p.m. Nov. 3, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 7:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant 7:30 a.m. Oct. 20, 2014 - PR Newswire - PRF
Halozyme Announces Podium Presentation On PEGPH20 At The New York Academy Of Sciences 8:00 a.m. Oct. 9, 2014 - PR Newswire - PRF
Halozyme Announces Issuance Of U.S. Patent For Companion Diagnostic For PEGPH20 7:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Halozyme Receives Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer 6:45 a.m. Oct. 3, 2014 - PR Newswire - PRF
SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 8:00 a.m. Sept. 18, 2014 - PR Newswire - PRF
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 7:45 a.m. Sept. 17, 2014 - PR Newswire - PRF
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency 6:02 p.m. Sept. 12, 2014 - BusinessWire - BZX
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 7:30 a.m. Sept. 3, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Halozyme to Host second Quarter 2014 Financial Results Conference Call 3:30 p.m. Aug. 4, 2014 - PR Newswire - PRF
FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency 12:55 p.m. July 31, 2014 - BusinessWire - BZX
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 8:00 a.m. July 22, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 6:20 a.m. July 10, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 5:20 a.m. July 2, 2014 - PR Newswire - PRF
Roche's Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme 7:00 a.m. June 25, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking Down on Insider Trading: Legal vs Illegal

Why the Insider Trading Line Isn't Always Clear-Cut Insider trading is one of those buzzwords that conjures up images of Wall Street shenanigans and pricey legal battles. But believe it or not, trading on insider info isn’t always a one-way ticket to a federal prison. What determines its legality often hinges on how the information was obtained and used. It's a...

NUH Revolutionizes Eye Care with Multidisciplinary Clinics

Looking Back at Four Decades of Eye Care Excellence Sitting in the middle of Singapore, the National University Hospital's Ophthalmology Department has chalked up a solid 40 years serving up top-notch eye care. This ain't just about celebrating another year; it's about shaking things up with fresh approaches to treating tricky eye disorders. They're not resting on any...

Dott's Q3 2026: Micromobility Growth Soars High

Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...

Harbour BioMed's Batoclimab Injected Into Myasthenia Market

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

GoldMining's 2025 Report: Zero Incidents, Big Green Goals

GoldMining Inc. Shows a Clear Green Streak Sometimes, you're caught off guard by a company's clear dedication to getting things right, and GoldMining Inc.'s latest sustainability report shows they're not just chasing fool's gold. They've laid out a solid roadmap. With the rollers they've got—swapping environmental chaos for responsible exploration—these guys have...

JJ Lin's Iconic Singapore Grand Prix Show With 20 Songs

Nothing beats the thrill of a live performance under a night sky, with the adrenaline of a Formula 1 race still in the air. On October 9, 2026, Mandopop superstar JJ Lin captivated the crowd at the Padang Stage of the Singapore Grand Prix, delivering not just a concert but a spectacle of international scale. Stage Spectacle with Precision JJ Lin took control like a...

Better Home & Finance Faces Class Action: What's Next?

Stock Hit and Legal Drama Panic set in when Better Home & Finance Holding Company took a 28.5% nosedive after spilling some less-than-sweet news. Their promise of hitting a billion in monthly loans? Stuck in limbo as borrower trepidation reared its ugly head amidst rising rates. Investors felt the heat, watching shares skydive $12.17, landing them at a bruised $30.52. A...

ANCEL's Super Starter Impresses with Performance Boost

More Than a Quick Fix: ANCEL's Impact Ever been frustrated because your car just won't start? Happens to the best of us, especially when that cold snap hits or your vehicle's been lounging around too long. ANCEL's Super Starter devices—let's talk about 'em. They've been making a name for themselves in the starting game, and I'm not yanking your chain here. According to...

Unicycive Faces Legal Heat Amid Stock Tumble

Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...

CardVault by Tom Brady Expands to Pittsburgh

Tom Brady’s CardVault Hits Pittsburgh’s Historic Strip District Pittsburgh just got another feather in its cap with CardVault by Tom Brady marking its 20th store at The Terminal. As if this city needed more sports excitement! Pittsburgh, with its die-hard Steelers, Penguins, and Pirates fans, snags a premium spot for sports collectibles. A Prime Spot for Serious...